Health Pharma

Avarice Is Truly So Addictive

Gilead’s Lenacapavir Price Cut: A Monopoly Tactic? Gilead Sciences’ recent announcement of reduced prices for lenacapavir, its innovative HIV prevention drug, in select nations has […]

Health Pharma

Gilead Art Project Reflects PBC Patients Journey Drives Focus On Patients In Studies

Raising Awareness of Primary Biliary Cholangitis Through Art Gilead Sciences is employing a unique strategy to increase understanding and recognition of primary biliary cholangitis (PBC): […]